
Metformin (1000mg) + Glimepiride (1mg)
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Endoglim M1 Tablet PR contains Glimepiride and Metformin, a combination medication designed to help manage blood glucose levels effectively. Glimepiride works by stimulating the pancreas to release insulin, which helps lower blood sugar levels. Metformin works by reducing glucose production in the liver and improving the body’s sensitivity to insulin. Together these medicines help maintain stable blood glucose levels and support effective diabetes management. The prolonged release formulation allows gradual release of the medicine, helping maintain consistent blood sugar control throughout the day. Proper glycemic management is important for reducing the risk of complications associated with diabetes and supporting metabolic health. The medicine is usually taken according to the dosage recommended by a healthcare professional. Healthy lifestyle habits such as balanced diet and regular exercise may further improve treatment effectiveness. When used as directed, Endoglim M1 Tablet PR helps support stable blood glucose levels and metabolic wellbeing.
How to use Endoglim M Tablet PR Use it as advised by your doctor or check the label for directions before use. Endoglim M1 Tablet PR is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Endoglim M1 Tablet PR.
High Risk
Endoglim M1 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Endoglim M1 Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Endoglim M1 Tablet PR may be needed. Please consult your doctor. Endoglim M1 Tablet PR is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.
Regular Checkup
Endoglim M1 Tablet PR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Endoglim M1 Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Endoglim M1 Tablet PR may be needed. Please consult your doctor. Use of Endoglim M1 Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Endoglim M1 Tablet PR

Glimepiride (1mg) + Metformin (1000mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Endoglim M1 Tablet PR contains Glimepiride and Metformin, a combination medication designed to help manage blood glucose levels effectively. Glimepiride works by stimulating the pancreas to release insulin, which helps lower blood sugar levels. Metformin works by reducing glucose production in the liver and improving the body’s sensitivity to insulin. Together these medicines help maintain stable blood glucose levels and support effective diabetes management. The prolonged release formulation allows gradual release of the medicine, helping maintain consistent blood sugar control throughout the day. Proper glycemic management is important for reducing the risk of complications associated with diabetes and supporting metabolic health. The medicine is usually taken according to the dosage recommended by a healthcare professional. Healthy lifestyle habits such as balanced diet and regular exercise may further improve treatment effectiveness. When used as directed, Endoglim M1 Tablet PR helps support stable blood glucose levels and metabolic wellbeing.
How to use Endoglim M Tablet PR Use it as advised by your doctor or check the label for directions before use. Endoglim M1 Tablet PR is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Endoglim M1 Tablet PR.
High Risk
Endoglim M1 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Endoglim M1 Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Endoglim M1 Tablet PR may be needed. Please consult your doctor. Endoglim M1 Tablet PR is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.
Regular Checkup
Endoglim M1 Tablet PR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Endoglim M1 Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Endoglim M1 Tablet PR may be needed. Please consult your doctor. Use of Endoglim M1 Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Endoglim M1 Tablet PR













